CTLA4 and cancer: ICIs, including inhibitors of programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), work by blocking the inhibitory signals that prevent T cells from attacking cancer cells.